First in Human Studies Show Activation of SC-DARIC33, a Rapamycin-Regulated Anti-CD33 CAR T Cell Therapy, in Patients with AML

MOLECULAR THERAPY(2023)

引用 0|浏览10
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要